Esophageal Squamous Cell Carcinoma Clinical Trials in Hefei, Anhui
4 recruitingHefei, Anhui, China
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC298 enrolled41 locationsNCT06780111
Recruiting
Phase 1Phase 2
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC230 enrolled57 locationsNCT05319730
Recruiting
Phase 2
Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital37 enrolled1 locationNCT07188103
Recruiting
Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer
Esophageal Squamous Cell CarcinomaChemoradiotherapyInitial Inoperable
Anhui Provincial Hospital97 enrolled1 locationNCT06190847